MedPath

RIDAURA

RIDAURA

Approved
DIN Number

01916823

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

xediton pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01916823
AIG Number0116168001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01CB03 AURANOFIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification60:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AURANOFINActive
Strength: 3 MG
Monograph: AURANOFIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.